CARING FOR PATIENTS WITH CANCER:@0.084848:0.038601:0.499679:0.038601:0.499679:0.019343:0.084848:0.019343:0.019121:0.017404:0.014276:0.005315:0.017404:0.020508:0.006515:0.011406:0.020438:0.014276:0.006515:0.012154:0.015492:0.010019:0.005315:0.012606:0.017404:0.010019:0.011712:0.006515:0.022578:0.005315:0.010019:0.016063:0.006515:0.019121:0.017404:0.017404:0.019121:0.012606:0.014276
132:@0.018436:0.038809:0.050045:0.038809:0.050045:0.019212:0.018436:0.019212:0.010536:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
In  the  era  of  ART,  and  despite high-risk :@0.084848:0.096166:0.481103:0.096166:0.481103:0.080410:0.084848:0.080410:0.004349:0.011738:0.005330:0.005490:0.006523:0.011738:0.012508:0.005330:0.005490:0.012508:0.005792:0.013143:0.005330:0.005488:0.012604:0.006042:0.005330:0.005486:0.014239:0.011786:0.006231:0.005330:0.005330:0.005488:0.013143:0.011738:0.013181:0.005330:0.005492:0.013181:0.012508:0.007466:0.013123:0.003848:0.006523:0.012508:0.010833:0.011738:0.003848:0.012950:0.011738:0.006388:0.005792:0.003848:0.007466:0.009660:0.005330
features and the treatment limitations :@0.084848:0.112557:0.481074:0.112557:0.481074:0.096801:0.084848:0.096801:0.006042:0.012508:0.013143:0.006523:0.011699:0.005707:0.012508:0.007466:0.015452:0.013143:0.011738:0.013181:0.015452:0.006523:0.011738:0.012508:0.015452:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.015452:0.003848:0.003848:0.018049:0.003848:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
highlighted above, the two-year overall :@0.084848:0.128947:0.481107:0.128947:0.481107:0.113192:0.084848:0.113192:0.011738:0.003848:0.012950:0.011738:0.003848:0.003848:0.012950:0.011738:0.006523:0.012508:0.013181:0.010564:0.013143:0.013123:0.012604:0.010660:0.012508:0.005330:0.010564:0.006523:0.011738:0.012508:0.010564:0.006523:0.015990:0.012604:0.006388:0.010314:0.012508:0.013143:0.005792:0.010564:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.005330
survival of HIV-DLBCL patients reaches 75% :@0.084848:0.145338:0.481080:0.145338:0.481080:0.129582:0.084848:0.129582:0.007466:0.011699:0.005792:0.010660:0.003848:0.010660:0.013143:0.003848:0.004478:0.012604:0.006042:0.004464:0.013143:0.004349:0.013508:0.006388:0.014316:0.008890:0.011045:0.015644:0.008890:0.004464:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.004464:0.005713:0.012508:0.013143:0.012450:0.011738:0.012508:0.007466:0.004464:0.010660:0.010660:0.014913:0.005330
and is similar to HIV-negative patients with :@0.084848:0.161729:0.481096:0.161729:0.481096:0.145973:0.084848:0.145973:0.013143:0.011738:0.013181:0.005359:0.003848:0.007466:0.005369:0.007466:0.003848:0.018049:0.003848:0.003848:0.013143:0.005792:0.005369:0.006523:0.012604:0.005357:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005369:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005359:0.015990:0.003848:0.006523:0.011738:0.005330
the same risk factors.:@0.084848:0.178120:0.278889:0.178120:0.278889:0.162364:0.084848:0.162364:0.006523:0.011738:0.012508:0.005330:0.007466:0.013143:0.018049:0.012508:0.005330:0.005792:0.003848:0.007466:0.009660:0.005330:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330
7:@0.278870:0.172475:0.285085:0.172475:0.285085:0.163289:0.278870:0.163289:0.006215
For  these reasons, HIV-related non-:@0.103030:0.194480:0.475785:0.194480:0.475785:0.178724:0.103030:0.178724:0.009333:0.012604:0.005792:0.005330:0.012417:0.006523:0.011738:0.012508:0.007466:0.012508:0.017761:0.005713:0.012508:0.013143:0.007466:0.012604:0.011738:0.007466:0.005330:0.017761:0.013143:0.004349:0.013508:0.006388:0.005721:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.017761:0.011738:0.012604:0.011738:0.006388
Hodgkin’s lymphoma should preferably :@0.084846:0.210871:0.481067:0.210871:0.481067:0.195115:0.084846:0.195115:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.014008:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.014008:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.014008:0.013123:0.005715:0.012508:0.006042:0.012508:0.005792:0.013143:0.013123:0.003848:0.010314:0.005330
be managed by experienced specialist :@0.084846:0.227261:0.481057:0.227261:0.481057:0.211506:0.084846:0.211506:0.013123:0.012508:0.010872:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.013181:0.010872:0.013123:0.010314:0.010872:0.012508:0.009236:0.013123:0.012508:0.005792:0.003848:0.012508:0.011738:0.012450:0.012498:0.013181:0.010872:0.007466:0.013123:0.012508:0.012450:0.003848:0.013143:0.003848:0.003848:0.007466:0.006523:0.005330
oncologists or under their guidance at the :@0.084846:0.243652:0.481124:0.243652:0.481124:0.227896:0.084846:0.227896:0.012604:0.011738:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.007466:0.006523:0.007466:0.005195:0.012604:0.005792:0.005195:0.011699:0.011738:0.013181:0.012508:0.005792:0.005195:0.006523:0.011738:0.012508:0.003848:0.005792:0.005195:0.012950:0.011699:0.003848:0.013181:0.013143:0.011738:0.012450:0.012508:0.005195:0.013143:0.006523:0.005195:0.006523:0.011738:0.012508:0.005330
very least.:@0.084846:0.260043:0.178268:0.260043:0.178268:0.244287:0.084846:0.244287:0.010660:0.012508:0.005792:0.010314:0.005330:0.003848:0.012508:0.013143:0.007466:0.006523:0.005330
Note:  Hodgkin’s lymphoma is the  most :@0.103030:0.276434:0.481090:0.276434:0.481090:0.260678:0.103030:0.260678:0.014239:0.012604:0.006523:0.012508:0.005330:0.005330:0.003173:0.013143:0.012604:0.013181:0.012950:0.009660:0.003848:0.011738:0.006754:0.007466:0.008524:0.003848:0.010314:0.018049:0.013123:0.011738:0.012604:0.018049:0.013143:0.008524:0.003848:0.007466:0.008524:0.006523:0.011738:0.012508:0.005330:0.003181:0.018049:0.012604:0.007466:0.006523:0.005330
common NADC and is 15- to 30-fold high-:@0.084846:0.292825:0.475783:0.292825:0.475783:0.277069:0.084846:0.277069:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005805:0.014239:0.014239:0.014316:0.015644:0.005817:0.013143:0.011738:0.013181:0.005819:0.003848:0.007466:0.005830:0.010660:0.010660:0.006388:0.005830:0.006523:0.012604:0.005811:0.010660:0.010660:0.006388:0.006042:0.012604:0.003848:0.013181:0.005830:0.011738:0.003848:0.012950:0.011738:0.006388
er  than  in  the  non-infected  population. :@0.084846:0.309216:0.481093:0.309216:0.481093:0.293460:0.084846:0.293460:0.012508:0.005792:0.005330:0.005523:0.006523:0.011738:0.013143:0.011738:0.005330:0.005528:0.003848:0.011738:0.005330:0.005530:0.006523:0.011738:0.012508:0.005330:0.005523:0.011738:0.012604:0.011738:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330:0.005517:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330
Treatment outcomes vary, depending on :@0.084846:0.325607:0.481093:0.325607:0.481093:0.309851:0.084846:0.309851:0.007620:0.005713:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.007079:0.012604:0.011699:0.006523:0.012440:0.012604:0.018049:0.012508:0.007466:0.007087:0.010660:0.013143:0.005792:0.010314:0.005330:0.007091:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.003848:0.011738:0.012950:0.007087:0.012604:0.011738:0.005330
the cohorts looked at. Although the inci-:@0.084846:0.341998:0.475781:0.341998:0.475781:0.326242:0.084846:0.326242:0.006523:0.011738:0.012508:0.007870:0.012450:0.012604:0.011738:0.012604:0.005792:0.006523:0.007466:0.007870:0.003848:0.012604:0.012604:0.009660:0.012508:0.013181:0.007870:0.013143:0.006523:0.005330:0.007870:0.014239:0.003848:0.006523:0.011738:0.012604:0.011686:0.012950:0.011738:0.007870:0.006523:0.011738:0.012508:0.007870:0.003848:0.011738:0.012450:0.003848:0.006388
dence of this disease has not decreased :@0.084846:0.358389:0.481101:0.358389:0.481101:0.342633:0.084846:0.342633:0.013181:0.012508:0.011738:0.012450:0.012508:0.007389:0.012604:0.006042:0.007389:0.006523:0.011738:0.003848:0.007466:0.007389:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.007389:0.011738:0.013143:0.007466:0.007389:0.011738:0.012604:0.006523:0.007389:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.013181:0.005330
since the introduction of ART, the progno-:@0.084846:0.374780:0.475756:0.374780:0.475756:0.359024:0.084846:0.359024:0.007466:0.003848:0.011738:0.012450:0.012508:0.006273:0.006523:0.011738:0.012508:0.006261:0.003848:0.011738:0.006523:0.005711:0.012604:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.006258:0.012604:0.006042:0.006258:0.014239:0.011788:0.006229:0.005330:0.006261:0.006523:0.011738:0.012508:0.006258:0.013123:0.005715:0.012604:0.012950:0.011738:0.012575:0.006388
sis has significantly improved. Some stud-:@0.084846:0.391171:0.475754:0.391171:0.475754:0.375415:0.084846:0.375415:0.007466:0.003848:0.007466:0.007912:0.011738:0.013143:0.007466:0.007905:0.007466:0.003848:0.012950:0.011738:0.003848:0.004686:0.004686:0.012450:0.013143:0.011738:0.006523:0.003848:0.010314:0.007907:0.003848:0.018049:0.013123:0.005719:0.012604:0.010660:0.012508:0.013181:0.005330:0.007897:0.009583:0.012604:0.018049:0.012508:0.007897:0.007466:0.006523:0.011699:0.013181:0.006388
ies show outcomes are similar for patients :@0.084846:0.407562:0.481092:0.407562:0.481092:0.391806:0.084846:0.391806:0.003848:0.012508:0.007466:0.006465:0.007466:0.011738:0.012604:0.015990:0.006454:0.012604:0.011699:0.006523:0.012450:0.012590:0.018049:0.012508:0.007466:0.006456:0.013143:0.005713:0.012508:0.006452:0.007466:0.003848:0.018049:0.003848:0.003848:0.013143:0.005805:0.006452:0.006042:0.012604:0.005792:0.006444:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
with similar stages and risk categories as :@0.084846:0.423953:0.481047:0.423953:0.481047:0.408197:0.084846:0.408197:0.015990:0.003848:0.006523:0.011738:0.008582:0.007466:0.003848:0.018049:0.003848:0.003848:0.013143:0.005792:0.008582:0.007466:0.006523:0.013143:0.012950:0.012508:0.007466:0.008582:0.013143:0.011738:0.013181:0.008582:0.005792:0.003848:0.007466:0.009660:0.008582:0.012450:0.013143:0.006523:0.012508:0.012950:0.012604:0.005792:0.003848:0.012508:0.007466:0.008582:0.013143:0.007466:0.005330
HIV-negative patients. This seems to be :@0.084846:0.440344:0.481067:0.440344:0.481067:0.424588:0.084846:0.424588:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.011084:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.011084:0.008197:0.011738:0.003848:0.007466:0.011084:0.007466:0.012508:0.012508:0.018049:0.007466:0.011084:0.006523:0.012604:0.011084:0.013123:0.012508:0.005330
mainly because HIV-positive patients tol-:@0.084846:0.456735:0.475756:0.456735:0.475756:0.440979:0.084846:0.440979:0.018049:0.013143:0.003848:0.011738:0.003848:0.010314:0.008717:0.013123:0.012508:0.012450:0.013143:0.011699:0.007466:0.012508:0.008717:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.008717:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008717:0.006523:0.012604:0.003848:0.006388
erate  standard  chemotherapy  regimens :@0.084846:0.473126:0.481088:0.473126:0.481088:0.457370:0.084846:0.457370:0.012508:0.005792:0.013143:0.006523:0.012508:0.005330:0.005042:0.007466:0.006523:0.013143:0.011738:0.013181:0.013143:0.005678:0.013181:0.005330:0.005049:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013108:0.010314:0.005330:0.005051:0.005713:0.012508:0.012950:0.003848:0.018049:0.012508:0.011738:0.007466:0.005330
well and can be treated in similar ways to :@0.084846:0.489516:0.481095:0.489516:0.481095:0.473761:0.084846:0.473761:0.015990:0.012508:0.003848:0.003848:0.005753:0.013143:0.011738:0.013181:0.005744:0.012450:0.013143:0.011738:0.005744:0.013123:0.012508:0.005742:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.005740:0.003848:0.011738:0.005753:0.007466:0.003848:0.018049:0.003848:0.003848:0.013143:0.005792:0.005753:0.015990:0.013143:0.010314:0.007466:0.005753:0.006523:0.012604:0.005330
their HIV-negative counterparts.:@0.084846:0.505907:0.381872:0.505907:0.381872:0.490151:0.084846:0.490151:0.006523:0.011738:0.012508:0.003848:0.005792:0.005330:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.012450:0.012604:0.011699:0.011738:0.006523:0.012508:0.005792:0.013123:0.013143:0.005792:0.006523:0.007466:0.005330
8:@0.381847:0.500188:0.388062:0.500188:0.388062:0.491002:0.381847:0.491002:0.006215
INVASIVE CERVICAL CANCER:@0.084848:0.538902:0.384175:0.538902:0.384175:0.521086:0.084848:0.521086:0.005987:0.015822:0.014966:0.015822:0.011118:0.005987:0.014966:0.011118:0.005987:0.016677:0.011118:0.012401:0.014966:0.005987:0.016677:0.015822:0.009407:0.005987:0.016677:0.015822:0.015822:0.016677:0.011118:0.012401
The  incidence  of  both  cervical dysplasia :@0.084848:0.556434:0.481065:0.556434:0.481065:0.540678:0.084848:0.540678:0.008197:0.011738:0.012508:0.005330:0.002925:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.005330:0.002933:0.012604:0.006042:0.005330:0.002929:0.013123:0.012604:0.006523:0.011738:0.005330:0.002929:0.012450:0.012508:0.005792:0.010660:0.003848:0.012450:0.013143:0.003848:0.008274:0.013181:0.010314:0.007466:0.013123:0.003848:0.013143:0.007466:0.003848:0.013143:0.005330
and neoplasia is significantly increased in :@0.084848:0.572825:0.481092:0.572825:0.481092:0.557069:0.084848:0.557069:0.013143:0.011738:0.013181:0.006943:0.011738:0.012508:0.012604:0.013123:0.003848:0.013143:0.007466:0.003848:0.013143:0.006956:0.003848:0.007466:0.006948:0.007466:0.003848:0.012950:0.011738:0.003848:0.004686:0.004686:0.012450:0.013143:0.011738:0.006523:0.003848:0.010314:0.006947:0.003848:0.011738:0.012450:0.005713:0.012508:0.013143:0.007466:0.012508:0.013181:0.006945:0.003848:0.011738:0.005330
HIV-infected women,  and the prognosis :@0.084848:0.589216:0.481096:0.589216:0.481096:0.573460:0.084848:0.573460:0.013143:0.004349:0.013508:0.006388:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.010545:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.005330:0.005203:0.013143:0.011738:0.013181:0.010545:0.006523:0.011738:0.012508:0.010545:0.013123:0.005715:0.012604:0.012950:0.011738:0.012604:0.007466:0.003848:0.007466:0.005330
is  worse compared with HIV-uninfected :@0.084848:0.605607:0.481082:0.605607:0.481082:0.589851:0.084848:0.589851:0.003848:0.007466:0.005330:0.006363:0.015990:0.012604:0.005792:0.007466:0.012508:0.011680:0.012450:0.012604:0.018049:0.013123:0.013143:0.005715:0.012508:0.013181:0.011680:0.015990:0.003848:0.006523:0.011738:0.011680:0.013143:0.004349:0.013508:0.006388:0.011699:0.011738:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.012508:0.013181:0.005330
women.  Unlike the positive effect of ART :@0.084848:0.621998:0.481104:0.621976:0.481104:0.606221:0.084848:0.606242:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.006207:0.007331:0.012604:0.011738:0.003848:0.003848:0.009660:0.012508:0.007331:0.006523:0.011738:0.012508:0.007316:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.007331:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007320:0.012604:0.006042:0.007320:0.014239:0.011786:0.008197:0.096996
9:@0.161057:0.616357:0.167272:0.616357:0.167272:0.607172:0.161057:0.607172:0.006215
on the incidence of NHL and KS, the im-:@0.084840:0.638367:0.475786:0.638367:0.475786:0.622611:0.084840:0.622611:0.012604:0.011738:0.007899:0.006523:0.011738:0.012508:0.007909:0.003848:0.011738:0.012450:0.003848:0.013181:0.012508:0.011738:0.012450:0.012508:0.007909:0.012604:0.006042:0.007909:0.014239:0.013143:0.008890:0.007909:0.013143:0.011738:0.013181:0.007909:0.011372:0.009583:0.005330:0.007909:0.006523:0.011738:0.012508:0.007897:0.003848:0.018049:0.006388
pact on cervical cancer  has been  mar-:@0.084840:0.654758:0.475764:0.654758:0.475764:0.639002:0.084840:0.639002:0.013123:0.013143:0.012450:0.006523:0.008832:0.012604:0.011738:0.008832:0.012450:0.012508:0.005792:0.010660:0.003848:0.012450:0.013143:0.003848:0.008832:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.003489:0.011738:0.013143:0.007466:0.008832:0.013123:0.012508:0.012508:0.011738:0.005330:0.003492:0.018049:0.013143:0.005792:0.006388
ginal to date.  The burden of HIV-related :@0.084840:0.671149:0.481094:0.671133:0.481094:0.655377:0.084840:0.655393:0.012950:0.003848:0.011738:0.013143:0.003848:0.006562:0.006523:0.012604:0.006548:0.013181:0.013143:0.006523:0.012508:0.005330:0.012436:0.006562:0.008197:0.011738:0.012508:0.006546:0.013123:0.011699:0.005677:0.013181:0.012508:0.011738:0.006550:0.012604:0.006042:0.006550:0.013143:0.004349:0.013508:0.006388:0.005719:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.025505
13:@0.213290:0.665514:0.225720:0.665514:0.225720:0.656329:0.213290:0.656329:0.006215:0.006215
cervical cancer  is in  sub-Saharan  Africa, :@0.084850:0.687524:0.481107:0.687524:0.481107:0.671768:0.084850:0.671768:0.012450:0.012508:0.005792:0.010660:0.003848:0.012450:0.013143:0.003848:0.008698:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.003348:0.003848:0.007466:0.008698:0.003848:0.011738:0.005330:0.003356:0.007466:0.011699:0.013123:0.006388:0.009583:0.013143:0.011738:0.013143:0.005792:0.013143:0.011738:0.005330:0.003358:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.005330
with the most important risk factor being :@0.084850:0.703915:0.481107:0.703915:0.481107:0.688159:0.084850:0.688159:0.015990:0.003848:0.006523:0.011738:0.008101:0.006523:0.011738:0.012508:0.008101:0.018049:0.012604:0.007466:0.006523:0.008101:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.008091:0.005792:0.003848:0.007466:0.009660:0.008101:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.008090:0.013123:0.012508:0.003848:0.011738:0.012950:0.005330
persistent HPV infection. Cervical cancer :@0.084850:0.720306:0.481098:0.720306:0.481098:0.704550:0.084850:0.704550:0.013123:0.012508:0.005792:0.007466:0.003848:0.007466:0.006523:0.012508:0.011738:0.006523:0.008197:0.013143:0.011392:0.013508:0.008197:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005330:0.008186:0.015644:0.012508:0.005792:0.010660:0.003848:0.012450:0.013143:0.003848:0.008197:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
is a direct result of this.:@0.084850:0.736697:0.291491:0.736697:0.291491:0.720941:0.084850:0.720941:0.003848:0.007466:0.005330:0.013143:0.005330:0.013181:0.003848:0.005721:0.012508:0.012450:0.006523:0.005330:0.005705:0.012508:0.007466:0.011699:0.003848:0.006523:0.005330:0.012604:0.006042:0.005330:0.006523:0.011738:0.003848:0.007466:0.005330
14:@0.291479:0.731057:0.303909:0.731057:0.303909:0.721871:0.291479:0.721871:0.006215:0.006215
Prevention:@0.084848:0.769771:0.193889:0.769771:0.193889:0.751750:0.084848:0.751750:0.011973:0.006842:0.013683:0.011973:0.013683:0.012828:0.006414:0.005131:0.013683:0.012828
Studies have shown that HPV vaccines are :@0.084848:0.787303:0.481069:0.787303:0.481069:0.771547:0.084848:0.771547:0.009583:0.006523:0.011699:0.013181:0.003848:0.012508:0.007466:0.004483:0.011738:0.013143:0.010660:0.012508:0.004483:0.007466:0.011738:0.012604:0.015990:0.011738:0.004483:0.006523:0.011738:0.013143:0.006523:0.004483:0.013143:0.011392:0.013508:0.004483:0.010660:0.013143:0.012450:0.012450:0.003848:0.011738:0.012508:0.007466:0.004483:0.013143:0.005715:0.012508:0.005330
well-tolerated  in  HIV-positive  HPV-nega-:@0.084848:0.803694:0.475760:0.803694:0.475760:0.787938:0.084848:0.787938:0.015990:0.012508:0.003848:0.003848:0.006388:0.006523:0.012604:0.003848:0.012508:0.005792:0.013143:0.006523:0.012508:0.013181:0.005330:0.006991:0.003848:0.011738:0.005330:0.006995:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012525:0.005330:0.006993:0.013143:0.011392:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006388
tive women, with high levels (75-100%) of :@0.084848:0.820085:0.481090:0.820085:0.481090:0.804329:0.084848:0.804329:0.006523:0.003848:0.010660:0.012508:0.007408:0.015990:0.012604:0.018049:0.012508:0.011738:0.005330:0.007408:0.015990:0.003848:0.006523:0.011738:0.007408:0.011738:0.003848:0.012950:0.011738:0.007408:0.003848:0.012508:0.010660:0.012508:0.003848:0.007466:0.007422:0.007100:0.010660:0.010660:0.006388:0.010660:0.010660:0.010660:0.014913:0.007100:0.007435:0.012604:0.006042:0.005330
seroconversion  for  HPV 6, 11, 16 and 18, :@0.084848:0.836476:0.481078:0.836476:0.481078:0.820720:0.084848:0.820720:0.007466:0.012508:0.005715:0.012604:0.012450:0.012604:0.011738:0.010660:0.012508:0.005792:0.007466:0.003848:0.012604:0.011738:0.005330:0.003235:0.006042:0.012604:0.005792:0.005330:0.003240:0.013143:0.011392:0.013508:0.008582:0.010660:0.005330:0.008582:0.010660:0.010660:0.005330:0.008582:0.010660:0.010660:0.008582:0.013143:0.011738:0.013181:0.008582:0.010660:0.010660:0.005330:0.005330
with the higher rates in women with CD4 :@0.084848:0.852867:0.481094:0.852867:0.481094:0.837111:0.084848:0.837111:0.015990:0.003848:0.006523:0.011738:0.007551:0.006523:0.011738:0.012508:0.007553:0.011738:0.003848:0.012950:0.011738:0.012508:0.005782:0.007551:0.005792:0.013143:0.006523:0.012508:0.007466:0.007549:0.003848:0.011738:0.007553:0.015990:0.012604:0.018049:0.012508:0.011738:0.007549:0.015990:0.003848:0.006523:0.011738:0.007551:0.015644:0.014316:0.010660:0.005330
counts >200 cells/µl.:@0.084848:0.869258:0.270422:0.869258:0.270422:0.853502:0.084848:0.853502:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.005330:0.011661:0.010660:0.010660:0.010660:0.005330:0.012450:0.012508:0.003848:0.003848:0.007466:0.008409:0.011084:0.003848:0.005330
Screening:@0.084848:0.902326:0.188757:0.902326:0.188757:0.884305:0.084848:0.884305:0.011118:0.013683:0.006842:0.013683:0.013683:0.012828:0.005131:0.012828:0.014111
In sub-Saharan Africa, the most important :@0.084848:0.919858:0.481105:0.919858:0.481105:0.904102:0.084848:0.904102:0.004349:0.011738:0.006061:0.007466:0.011699:0.013123:0.006388:0.009583:0.013143:0.011738:0.013143:0.005792:0.013143:0.011738:0.006061:0.014239:0.006042:0.005792:0.003848:0.012450:0.013143:0.005330:0.006050:0.006523:0.011738:0.012508:0.006052:0.018049:0.012604:0.007466:0.006523:0.006061:0.003848:0.018049:0.013123:0.012604:0.005792:0.006523:0.013143:0.011738:0.006523:0.005330
limiting factor to screening is access. The :@0.084848:0.936249:0.481103:0.936249:0.481103:0.920493:0.084848:0.920493:0.003848:0.003848:0.018049:0.003848:0.006523:0.003848:0.011738:0.012950:0.007524:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007506:0.006523:0.012604:0.007514:0.007466:0.012450:0.005715:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.007508:0.003848:0.007466:0.007524:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.005330:0.007524:0.008197:0.011738:0.012508:0.005330
various  screening  methods  –  PAP,  HPV :@0.524249:0.096170:0.920492:0.096170:0.920492:0.080415:0.524249:0.080415:0.010660:0.013143:0.005792:0.003848:0.012604:0.011699:0.007466:0.005330:0.007976:0.007466:0.012450:0.005715:0.012508:0.012508:0.011738:0.003848:0.011738:0.012950:0.005330:0.007970:0.018049:0.012508:0.006523:0.011738:0.012604:0.013181:0.007466:0.005330:0.007966:0.009621:0.005330:0.007972:0.009960:0.014239:0.009015:0.005330:0.005330:0.007968:0.013143:0.011392:0.013508:0.005330
DNA testing, visual inspection using acetic :@0.524249:0.112614:0.920488:0.112614:0.920488:0.096858:0.524249:0.096858:0.014316:0.014239:0.014239:0.005215:0.006523:0.012508:0.007466:0.006523:0.003848:0.011738:0.012950:0.005330:0.005215:0.010660:0.003848:0.007466:0.011699:0.013143:0.003848:0.005234:0.003848:0.011738:0.007466:0.013123:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005215:0.011699:0.007466:0.003848:0.011738:0.012950:0.005215:0.013143:0.012450:0.012508:0.006523:0.003848:0.012450:0.005330
acid or Lugol’s iodine are sporadic, if at all :@0.524249:0.129058:0.920479:0.129058:0.920479:0.113302:0.524249:0.113302:0.013143:0.012450:0.003848:0.013181:0.004907:0.012604:0.005792:0.004897:0.008890:0.011699:0.012950:0.012604:0.003848:0.006754:0.007466:0.004907:0.003848:0.012604:0.013181:0.003848:0.011738:0.012508:0.004907:0.013143:0.005715:0.012508:0.004907:0.007466:0.013123:0.012604:0.005792:0.013143:0.013181:0.003848:0.012450:0.005330:0.004907:0.003848:0.006042:0.004907:0.013143:0.006523:0.004907:0.013143:0.003848:0.003848:0.005330
available. In countries with limited resourc-:@0.524249:0.145502:0.915152:0.145502:0.915152:0.129746:0.524249:0.129746:0.013143:0.010660:0.013143:0.003848:0.003848:0.013143:0.013123:0.003848:0.012508:0.005330:0.004659:0.004349:0.011738:0.004637:0.012450:0.012604:0.011699:0.011738:0.006523:0.005792:0.003848:0.012508:0.007466:0.004637:0.015990:0.003848:0.006523:0.011738:0.004637:0.003848:0.003848:0.018049:0.003848:0.006523:0.012508:0.013181:0.004637:0.005713:0.012508:0.007466:0.012604:0.011699:0.005651:0.012450:0.006388
es, various models have been proposed. :@0.524249:0.161946:0.920488:0.161946:0.920488:0.146190:0.524249:0.146190:0.012508:0.007466:0.005330:0.007832:0.010660:0.013143:0.005792:0.003848:0.012604:0.011699:0.007466:0.007832:0.018049:0.012604:0.013181:0.012508:0.003848:0.007466:0.007832:0.011738:0.013143:0.010660:0.012508:0.007832:0.013123:0.012508:0.012508:0.011738:0.007832:0.013123:0.005715:0.012604:0.013123:0.012604:0.007466:0.012508:0.013181:0.005330:0.005330
Most successful seems to be a combina-:@0.524249:0.178390:0.915158:0.178390:0.915158:0.162634:0.524249:0.162634:0.017684:0.012604:0.007466:0.006523:0.007716:0.007466:0.011699:0.012450:0.012450:0.012508:0.007466:0.007466:0.006042:0.011699:0.003848:0.007716:0.007466:0.012508:0.012508:0.018049:0.007466:0.007716:0.006523:0.012604:0.007716:0.013123:0.012508:0.007716:0.013143:0.007716:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006388
tion of “see and treat”. Pre-malignant le-:@0.524249:0.194834:0.915147:0.194834:0.915147:0.179078:0.524249:0.179078:0.006523:0.003848:0.012604:0.011738:0.007428:0.012604:0.006042:0.007428:0.009660:0.007466:0.012508:0.012508:0.007428:0.013143:0.011738:0.013181:0.007428:0.006523:0.005709:0.012508:0.013143:0.006523:0.009313:0.005330:0.007428:0.011392:0.005709:0.012508:0.006388:0.018049:0.013143:0.003848:0.003848:0.012950:0.011738:0.013143:0.011738:0.006523:0.007428:0.003848:0.012508:0.006388
sions are treated on the same-day visit to :@0.524249:0.211277:0.920494:0.211277:0.920494:0.195521:0.524249:0.195521:0.007466:0.003848:0.012604:0.011738:0.007466:0.006504:0.013143:0.005715:0.012508:0.006504:0.006523:0.005711:0.012508:0.013143:0.006523:0.012508:0.013181:0.006504:0.012604:0.011738:0.006504:0.006523:0.011738:0.012508:0.006504:0.007466:0.013143:0.018049:0.012508:0.006388:0.013181:0.013143:0.010314:0.006517:0.010660:0.003848:0.007466:0.003848:0.006523:0.006519:0.006523:0.012604:0.005330
reduce loss to follow-up.:@0.524249:0.227721:0.750287:0.227721:0.750287:0.211965:0.524249:0.211965:0.005713:0.012508:0.013181:0.011699:0.012450:0.012508:0.005330:0.003848:0.012604:0.007466:0.007466:0.005330:0.006523:0.012604:0.005330:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.006388:0.011699:0.013123:0.005330
The age at presentation of changes is on :@0.524249:0.244165:0.920500:0.244165:0.920500:0.228409:0.524249:0.228409:0.008197:0.011738:0.012508:0.006639:0.013143:0.012950:0.012508:0.006639:0.013143:0.006523:0.006639:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.006639:0.012604:0.006042:0.006639:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466:0.006639:0.003848:0.007466:0.006650:0.012604:0.011738:0.005330
average 10 years younger in HIV-positive :@0.524249:0.260609:0.920456:0.260609:0.920456:0.244853:0.524249:0.244853:0.013143:0.010660:0.012508:0.005792:0.013143:0.012950:0.012508:0.007697:0.010660:0.010660:0.007697:0.010314:0.012508:0.013143:0.005792:0.007466:0.007697:0.010314:0.012604:0.011699:0.011738:0.012950:0.012508:0.005792:0.007683:0.003848:0.011738:0.007697:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330
versus:@0.524249:0.277053:0.579840:0.277053:0.579840:0.261297:0.524249:0.261297:0.010660:0.012508:0.005792:0.007466:0.011699:0.007466
 HIV-negative patients.:@0.579840:0.277053:0.791968:0.277053:0.791968:0.261297:0.579840:0.261297:0.005330:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330
Treatment:@0.524242:0.310252:0.627296:0.310252:0.627296:0.292231:0.524242:0.292231:0.008980:0.006842:0.013683:0.014111:0.006414:0.020098:0.013683:0.012828:0.006414
Management  of  immunosuppression:  As :@0.524242:0.327842:0.920483:0.327842:0.920483:0.312086:0.524242:0.312086:0.017684:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005330:0.005498:0.012604:0.006042:0.005330:0.005505:0.003848:0.018049:0.018049:0.011699:0.011738:0.012604:0.007466:0.011699:0.013123:0.013123:0.005715:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.005509:0.014239:0.007466:0.005330
per  guidelines,  ART  should  be  instituted :@0.524242:0.344286:0.920476:0.344286:0.920476:0.328530:0.524242:0.328530:0.013123:0.012508:0.005792:0.005330:0.005931:0.012950:0.011699:0.003848:0.013181:0.012508:0.003848:0.003848:0.011738:0.012508:0.007466:0.005330:0.005330:0.005932:0.014239:0.011788:0.008197:0.005330:0.005929:0.007466:0.011738:0.012604:0.011699:0.003848:0.013181:0.005330:0.005932:0.013123:0.012508:0.005330:0.005931:0.003848:0.011738:0.007466:0.006523:0.003848:0.006523:0.011699:0.006523:0.012508:0.013181:0.005330
in patients at the appropriate CD4  level :@0.524242:0.360729:0.920458:0.360729:0.920458:0.344973:0.524242:0.344973:0.003848:0.011738:0.008890:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.008890:0.013143:0.006523:0.008890:0.006523:0.011738:0.012508:0.008890:0.013143:0.013123:0.013123:0.005719:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508:0.008890:0.015644:0.014316:0.010660:0.005330:0.003571:0.003848:0.012508:0.010660:0.012508:0.003848:0.005330
count along with other prophylactic meas-:@0.524242:0.377173:0.915149:0.377173:0.915149:0.361417:0.524242:0.361417:0.012450:0.012604:0.011699:0.011738:0.006523:0.003575:0.013143:0.003848:0.012604:0.011738:0.012950:0.003583:0.015990:0.003848:0.006523:0.011738:0.003585:0.012604:0.006523:0.011738:0.012508:0.005792:0.003571:0.013123:0.005715:0.012604:0.013123:0.011738:0.010314:0.003848:0.013143:0.012450:0.006523:0.003848:0.012450:0.003598:0.018049:0.012508:0.013143:0.007466:0.006388
ures and vaccinations as per guidelines.:@0.524242:0.393617:0.896906:0.393617:0.896906:0.377861:0.524242:0.377861:0.011699:0.005711:0.012508:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.010660:0.013143:0.012450:0.012450:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.013143:0.007466:0.005330:0.013123:0.012508:0.005792:0.005330:0.012950:0.011699:0.003848:0.013181:0.012508:0.003848:0.003848:0.011738:0.012508:0.007466:0.005330
Standard staging in lower- to middle-in-:@0.542426:0.410061:0.915132:0.410061:0.915132:0.394305:0.542426:0.394305:0.009583:0.006523:0.013143:0.011738:0.013181:0.013143:0.005677:0.013181:0.006619:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.006619:0.003848:0.011738:0.006619:0.003848:0.012604:0.015990:0.012508:0.005792:0.006388:0.006619:0.006523:0.012604:0.006619:0.018049:0.003848:0.013181:0.013181:0.003848:0.012508:0.006388:0.003848:0.011738:0.006388
come countries (LMIC) is pelvic examina-:@0.524242:0.426505:0.915126:0.426505:0.915126:0.410749:0.524242:0.410749:0.012450:0.012604:0.018049:0.012508:0.006812:0.012450:0.012604:0.011699:0.011738:0.006523:0.005792:0.003848:0.012508:0.007466:0.006812:0.007100:0.008890:0.017684:0.004349:0.015644:0.007100:0.006812:0.003848:0.007466:0.006825:0.013123:0.012508:0.003848:0.010660:0.003848:0.012450:0.006812:0.012508:0.009236:0.013143:0.018049:0.003848:0.011738:0.013143:0.006388
tion (by a suitably trained physician), CXR :@0.524242:0.442949:0.920478:0.442949:0.920478:0.427193:0.524242:0.427193:0.006523:0.003848:0.012604:0.011738:0.006104:0.007100:0.013123:0.010314:0.006108:0.013143:0.006119:0.007466:0.011699:0.003848:0.006523:0.013143:0.013123:0.003848:0.010314:0.006119:0.006523:0.005792:0.013143:0.003848:0.011738:0.012508:0.013181:0.006104:0.013123:0.011738:0.010314:0.007466:0.003848:0.012450:0.003848:0.013143:0.011738:0.007100:0.005330:0.006119:0.015644:0.011719:0.011680:0.005330
and ultrasound to exclude hydronephrosis :@0.524242:0.459392:0.920487:0.459392:0.920487:0.443637:0.524242:0.443637:0.013143:0.011738:0.013181:0.005215:0.011699:0.003848:0.006523:0.005792:0.013143:0.007466:0.012604:0.011699:0.011738:0.013181:0.005215:0.006523:0.012604:0.005215:0.012508:0.009236:0.012450:0.003848:0.011699:0.013181:0.012508:0.005215:0.011738:0.010314:0.013181:0.005713:0.012604:0.011738:0.012508:0.013123:0.011738:0.005703:0.012604:0.007466:0.003848:0.007466:0.005330
which is indicative of the more advanced :@0.524242:0.475836:0.920487:0.475836:0.920487:0.460080:0.524242:0.460080:0.015990:0.011738:0.003848:0.012450:0.011738:0.005638:0.003848:0.007466:0.005638:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.010660:0.012508:0.005638:0.012604:0.006042:0.005626:0.006523:0.011738:0.012508:0.005625:0.018049:0.012604:0.005707:0.012508:0.005638:0.013143:0.013181:0.010660:0.013143:0.011738:0.012450:0.012508:0.013181:0.005330
stages  at  presentation.  In  well-resourced :@0.524242:0.492280:0.920485:0.492280:0.920485:0.476524:0.524242:0.476524:0.007466:0.006523:0.013143:0.012950:0.012508:0.007466:0.005330:0.003666:0.013143:0.006523:0.005330:0.003664:0.013123:0.005715:0.012508:0.007466:0.012508:0.011738:0.006523:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330:0.003652:0.004349:0.011738:0.005330:0.003664:0.015990:0.012508:0.003848:0.003848:0.006388:0.005721:0.012508:0.007466:0.012604:0.011699:0.005653:0.012450:0.012508:0.013181:0.005330
situations, the  staging and primary work-:@0.524242:0.508724:0.915178:0.508724:0.915178:0.492968:0.524242:0.492968:0.007466:0.003848:0.006523:0.011699:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330:0.008563:0.006523:0.011738:0.012508:0.005330:0.003221:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.008563:0.013143:0.011738:0.013181:0.008563:0.013123:0.005792:0.003848:0.018049:0.013143:0.005792:0.010314:0.008563:0.015990:0.012604:0.005792:0.009660:0.006388
up would be the same regardless of HIV-:@0.524242:0.525168:0.915153:0.525168:0.915153:0.509412:0.524242:0.509412:0.011699:0.013123:0.007243:0.015990:0.012604:0.011699:0.003848:0.013181:0.007243:0.013123:0.012508:0.007245:0.006523:0.011738:0.012508:0.007235:0.007466:0.013143:0.018049:0.012508:0.007254:0.005711:0.012508:0.012950:0.013143:0.005673:0.013181:0.003848:0.012508:0.007466:0.007466:0.007254:0.012604:0.006042:0.007239:0.013143:0.004349:0.013508:0.006388
status. The benefit of PET-CT :@0.524242:0.541612:0.792539:0.541612:0.792539:0.525856:0.524242:0.525856:0.007466:0.006523:0.013143:0.006523:0.011699:0.007466:0.005330:0.006960:0.008197:0.011738:0.012508:0.006956:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.006952:0.012604:0.006042:0.006956:0.011392:0.010314:0.008197:0.006388:0.015644:0.008197:0.005330
versus:@0.794155:0.541612:0.849746:0.541612:0.849746:0.525856:0.794155:0.525856:0.010660:0.012508:0.005792:0.007466:0.011699:0.007466
 stand-:@0.849746:0.541612:0.915151:0.541612:0.915151:0.525856:0.849746:0.525856:0.006966:0.007466:0.006523:0.013143:0.011738:0.013181:0.006388
ard CT-scans in HIV-positive patients is :@0.524242:0.558056:0.920481:0.558056:0.920481:0.542300:0.524242:0.542300:0.013143:0.005677:0.013181:0.013335:0.015644:0.008197:0.006388:0.007466:0.012450:0.013143:0.011738:0.007466:0.013335:0.003848:0.011738:0.013335:0.013143:0.004349:0.013508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.013335:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.013335:0.003848:0.007466:0.005330
beset with issues of false-positive  nodal :@0.524242:0.574499:0.920456:0.574499:0.920456:0.558744:0.524242:0.558744:0.013123:0.012508:0.007466:0.012508:0.006523:0.011411:0.015990:0.003848:0.006523:0.011738:0.011411:0.003848:0.007466:0.007466:0.011699:0.012508:0.007466:0.011411:0.012604:0.006042:0.011411:0.006042:0.013143:0.003848:0.007466:0.012508:0.006388:0.013123:0.012604:0.007466:0.003848:0.006523:0.003848:0.010660:0.012508:0.005330:0.006094:0.011738:0.012604:0.013181:0.013143:0.003848:0.005330
detection due to HIV/AIDS. CT-scan along :@0.524242:0.590943:0.920481:0.590943:0.920481:0.575187:0.524242:0.575187:0.013181:0.012508:0.006523:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738:0.005195:0.013181:0.011699:0.012508:0.005195:0.006523:0.012604:0.005195:0.013143:0.004349:0.013508:0.008409:0.014239:0.004349:0.014316:0.009583:0.005330:0.005195:0.015644:0.008197:0.006388:0.007466:0.012450:0.013143:0.011738:0.005195:0.013143:0.003848:0.012604:0.011738:0.012950:0.005330
with surgical staging seems to be indicat-:@0.524242:0.607387:0.915176:0.607387:0.915176:0.591631:0.524242:0.591631:0.015990:0.003848:0.006523:0.011738:0.006523:0.007466:0.011699:0.005809:0.012950:0.003848:0.012450:0.013143:0.003848:0.006523:0.007466:0.006523:0.013143:0.012950:0.003848:0.011738:0.012950:0.006512:0.007466:0.012508:0.012508:0.018049:0.007466:0.006523:0.006523:0.012604:0.006523:0.013123:0.012508:0.006523:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.006388
ed as per the clinical indications.:@0.524242:0.623831:0.830273:0.623831:0.830273:0.608075:0.524242:0.608075:0.012508:0.013181:0.005330:0.013143:0.007466:0.005330:0.013123:0.012508:0.005792:0.005330:0.006523:0.011738:0.012508:0.005330:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005330:0.003848:0.011738:0.013181:0.003848:0.012450:0.013143:0.006523:0.003848:0.012604:0.011738:0.007466:0.005330
Surgery and/or chemoradiation are the :@0.542426:0.640275:0.920512:0.640275:0.920512:0.624519:0.542426:0.624519:0.009583:0.011699:0.005805:0.012950:0.012508:0.005792:0.010314:0.006485:0.013143:0.011738:0.013181:0.008409:0.012604:0.005792:0.006485:0.012450:0.011738:0.012508:0.018049:0.012604:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.006485:0.013143:0.005713:0.012508:0.006485:0.006523:0.011738:0.012508:0.005330
cornerstones of cervical cancer manage-:@0.524242:0.656719:0.915167:0.656719:0.915167:0.640963:0.524242:0.640963:0.012450:0.012604:0.006186:0.011738:0.012508:0.005792:0.007466:0.006523:0.012604:0.011738:0.012508:0.007466:0.005490:0.012604:0.006042:0.005503:0.012450:0.012508:0.005792:0.010660:0.003848:0.012450:0.013143:0.003848:0.005503:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005503:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.006388
ment and the treatment is as per HIV-neg-:@0.524242:0.673163:0.915142:0.673163:0.915142:0.657407:0.524242:0.657407:0.018049:0.012508:0.011738:0.006523:0.005099:0.013143:0.011738:0.013181:0.005099:0.006523:0.011738:0.012508:0.005099:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005099:0.003848:0.007466:0.005113:0.013143:0.007466:0.005099:0.013123:0.012508:0.005792:0.005099:0.013143:0.004349:0.013508:0.006388:0.011738:0.012508:0.012950:0.006388
ative patients, guided by disease stage :@0.524242:0.689606:0.920481:0.689606:0.920481:0.673850:0.524242:0.673850:0.013143:0.006523:0.003848:0.010660:0.012508:0.010102:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.010102:0.012950:0.011699:0.003848:0.013181:0.012508:0.013181:0.010102:0.013123:0.010314:0.010102:0.013181:0.003848:0.007466:0.012508:0.013143:0.007466:0.012508:0.010102:0.007466:0.006523:0.013143:0.012950:0.012508:0.005330
and patient factors.  Access to  trained :@0.524242:0.706050:0.920497:0.706050:0.920497:0.690294:0.524242:0.690294:0.013143:0.011738:0.013181:0.012738:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.012738:0.006042:0.013143:0.012450:0.006523:0.012604:0.005792:0.007466:0.005330:0.005330:0.007395:0.014239:0.012450:0.012450:0.012508:0.007466:0.007466:0.012738:0.006523:0.012604:0.005330:0.007399:0.006523:0.005792:0.013143:0.003848:0.011738:0.012508:0.013181:0.005330
gynaecological surgeons and to radiation :@0.524242:0.722494:0.920479:0.722494:0.920479:0.706738:0.524242:0.706738:0.012950:0.010314:0.011738:0.013143:0.012508:0.012450:0.012604:0.003848:0.012604:0.012950:0.003848:0.012450:0.013143:0.003848:0.004818:0.007466:0.011699:0.005809:0.012950:0.012508:0.012604:0.011738:0.007466:0.004811:0.013143:0.011738:0.013181:0.004820:0.006523:0.012604:0.004813:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
facilities  is severely lacking in the areas :@0.524242:0.738938:0.920456:0.738938:0.920456:0.723182:0.524242:0.723182:0.006042:0.013143:0.012450:0.003848:0.003848:0.003848:0.006523:0.003848:0.012508:0.007466:0.005330:0.005444:0.003848:0.007466:0.010757:0.007466:0.012508:0.010660:0.012508:0.005711:0.012508:0.003848:0.010314:0.010757:0.003848:0.013143:0.012450:0.009660:0.003848:0.011738:0.012950:0.010757:0.003848:0.011738:0.010757:0.006523:0.011738:0.012508:0.010757:0.013143:0.005715:0.012508:0.013143:0.007466:0.005330
where this is  most needed. Neoadjuvant :@0.524242:0.755382:0.920487:0.755382:0.920487:0.739626:0.524242:0.739626:0.015990:0.011738:0.012508:0.005709:0.012508:0.008524:0.006523:0.011738:0.003848:0.007466:0.008524:0.003848:0.007466:0.005330:0.003206:0.018049:0.012604:0.007466:0.006523:0.008524:0.011738:0.012508:0.012508:0.013181:0.012508:0.013181:0.005330:0.008524:0.014239:0.012508:0.012604:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.005330
chemotherapy followed by radical hyster-:@0.524242:0.771826:0.915153:0.771826:0.915153:0.756070:0.524242:0.756070:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005043:0.006042:0.012604:0.003848:0.003848:0.012604:0.015990:0.012508:0.013181:0.005061:0.013123:0.010314:0.005061:0.005792:0.013143:0.013181:0.003848:0.012450:0.013143:0.003848:0.005061:0.011738:0.010314:0.007466:0.006523:0.012508:0.005792:0.006388
ectomy is a common approach in areas :@0.524242:0.788270:0.920489:0.788270:0.920489:0.772514:0.524242:0.772514:0.012508:0.012450:0.006523:0.012604:0.018049:0.010314:0.007645:0.003848:0.007466:0.007658:0.013143:0.007658:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.007645:0.013143:0.013123:0.013123:0.005721:0.012604:0.013143:0.012450:0.011738:0.007649:0.003848:0.011738:0.007658:0.013143:0.005715:0.012508:0.013143:0.007466:0.005330
without access to radiation.:@0.524242:0.804713:0.782917:0.804713:0.782917:0.788957:0.524242:0.788957:0.015990:0.003848:0.006523:0.011738:0.012604:0.011699:0.006523:0.005330:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.005330:0.006523:0.012604:0.005330:0.005792:0.013143:0.013181:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
Palliative  care is part of an overall ap-:@0.542426:0.821157:0.915145:0.821157:0.915145:0.805401:0.542426:0.805401:0.011392:0.013143:0.003848:0.003848:0.003848:0.013143:0.006523:0.003848:0.010660:0.012508:0.005330:0.002921:0.012450:0.013143:0.005713:0.012508:0.008236:0.003848:0.007466:0.008236:0.013123:0.013143:0.005792:0.006523:0.008236:0.012604:0.006042:0.008236:0.013143:0.011738:0.008236:0.012604:0.010660:0.012508:0.005792:0.013143:0.003848:0.003848:0.008236:0.013143:0.013123:0.006388
proach to the management of all cancer :@0.524242:0.837601:0.920499:0.837601:0.920499:0.821845:0.524242:0.821845:0.013123:0.005715:0.012604:0.013143:0.012450:0.011738:0.005721:0.006523:0.012604:0.005721:0.006523:0.011738:0.012508:0.005719:0.018049:0.013143:0.011738:0.013143:0.012950:0.012508:0.018049:0.012508:0.011738:0.006523:0.005717:0.012604:0.006042:0.005734:0.013143:0.003848:0.003848:0.005734:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330
patients, and often is all that is available :@0.524242:0.854045:0.920453:0.854045:0.920453:0.838289:0.524242:0.838289:0.013123:0.013143:0.006523:0.003848:0.012508:0.011738:0.006523:0.007466:0.005330:0.007793:0.013143:0.011738:0.013181:0.007793:0.012604:0.006042:0.006523:0.012508:0.011738:0.007784:0.003848:0.007466:0.007793:0.013143:0.003848:0.003848:0.007793:0.006523:0.011738:0.013143:0.006523:0.007793:0.003848:0.007466:0.007793:0.013143:0.010660:0.013143:0.003848:0.003848:0.013143:0.013123:0.003848:0.012508:0.005330
in low-resource regions. The lack of access :@0.524242:0.870489:0.920476:0.870489:0.920476:0.854733:0.524242:0.854733:0.003848:0.011738:0.004676:0.003848:0.012604:0.015990:0.006388:0.005715:0.012508:0.007466:0.012604:0.011699:0.005653:0.012450:0.012508:0.004676:0.005713:0.012508:0.012950:0.003848:0.012604:0.011738:0.007466:0.005330:0.004676:0.008197:0.011738:0.012508:0.004676:0.003848:0.013143:0.012450:0.009660:0.004676:0.012604:0.006042:0.004676:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.005330
to  opioids is problematic.  Eighty  percent :@0.524242:0.886933:0.920497:0.886933:0.920497:0.871177:0.524242:0.871177:0.006523:0.012604:0.005330:0.003329:0.012604:0.013123:0.003848:0.012604:0.003848:0.013181:0.007466:0.008678:0.003848:0.007466:0.008678:0.013123:0.005715:0.012604:0.013123:0.003848:0.012508:0.018049:0.013143:0.006523:0.003848:0.012450:0.005330:0.005330:0.003337:0.010314:0.003848:0.012950:0.011738:0.006523:0.010314:0.005330:0.003337:0.013123:0.012508:0.005657:0.012450:0.012508:0.011738:0.006523:0.005330
of the global population lack access  to :@0.524242:0.903377:0.920474:0.903377:0.920474:0.887621:0.524242:0.887621:0.012604:0.006042:0.009333:0.006523:0.011738:0.012508:0.009333:0.012950:0.003848:0.012604:0.013123:0.013143:0.003848:0.009333:0.013123:0.012604:0.013123:0.011699:0.003848:0.013143:0.006523:0.003848:0.012604:0.011738:0.009333:0.003848:0.013143:0.012450:0.009660:0.009333:0.013143:0.012450:0.012450:0.012508:0.007466:0.007466:0.005330:0.004014:0.006523:0.012604:0.005330
appropriate opioid analgesics, based on :@0.524242:0.919820:0.920485:0.919820:0.920485:0.904064:0.524242:0.904064:0.013143:0.013123:0.013123:0.005719:0.012604:0.013123:0.005792:0.003848:0.013143:0.006523:0.012508:0.007851:0.012604:0.013123:0.003848:0.012604:0.003848:0.013181:0.007851:0.013143:0.011738:0.013143:0.003848:0.012950:0.012508:0.007466:0.003848:0.012450:0.007466:0.005330:0.007851:0.013123:0.013143:0.007466:0.012508:0.013181:0.007851:0.012604:0.011738:0.005330
a WHO estimate.:@0.524242:0.936264:0.682280:0.936264:0.682280:0.920508:0.524242:0.920508:0.013143:0.005330:0.018473:0.013143:0.016722:0.005330:0.012508:0.007466:0.006523:0.003848:0.018049:0.013143:0.006523:0.012508:0.005330
16:@0.682278:0.930625:0.694708:0.930625:0.694708:0.921439:0.682278:0.921439:0.006215:0.006215